Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Diabetes, Obesity & Metabolism|September 16, 2024
Detection of hypoglycaemia in type 1 diabetes through breath volatile organic compound profiling using gas chromatography-ion mobility spectrometryCléo Nicolier, Juri Künzler, Aritz Lizoain, et al.
Swiss Medical Weekly|April 3, 2023
Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023)Giacomo Gastaldi, Barbara Lucchini, Sebastien Thalmann, et al.
Journal of Psychosomatic Research|June 12, 2024
Depression and anxiety symptoms are underestimated risk factors for postoperative prognosis in patients with Type 2 diabetes and peripheral artery disease undergoing partial foot amputation: Results from a prospective cohort studyEvgeniya Shalaeva, Arjola Bano, Ulugbek Kasimov, et al.
Diabetes Technology & Therapeutics|December 22, 2021
Use and Perception of Telemedicine in People with Type 1 Diabetes During the COVID-19 Pandemic: A 1-Year Follow-UpSam N Scott, Federico Y Fontana, Simon Helleputte, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 5, 2020
Comparing diabetes due to diseases of the exocrine pancreas to type 1 and type 2 diabetes using propensity score matchingStefanie Lanzinger, Wolfram Karges, Sigrun Merger, et al.
Obesity (Silver Spring, Md.)|February 2, 2008
The Taq1B-variant in the cholesteryl ester-transfer protein gene and the risk of metabolic syndromeAnton Sandhofer, Tobias Tatarczyk, Markus Laimer, et al.
Journal of Sports Science & Medicine|March 28, 2017
The Effects of 3 Weeks of Uphill and Downhill Walking on Blood Lipids and Glucose Metabolism in Pre-Diabetic Men: A Pilot StudyMarc Philippe, Hannes Gatterer, Erika Maria Eder, et al.
Obesity (Silver Spring, Md.)|July 21, 2006
Cholesteryl ester transfer protein in metabolic syndromeAnton Sandhofer, Susanne Kaser, Andreas Ritsch, et al.
Obesity Research|July 10, 2002
Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptinMarkus Laimer, Christoph F Ebenbichler, Susanne Kaser, et al.
Obesity Facts|May 27, 2015
Normobaric Intermittent Hypoxia over 8 Months Does Not Reduce Body Weight and Metabolic Risk Factors--a Randomized, Single Blind, Placebo-Controlled Study in Normobaric Hypoxia and Normobaric Sham HypoxiaHannes Gatterer, Sven Haacke, Martin Burtscher, et al.
Pageof 10